These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8633408)

  • 1. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results.
    Cohen JK; Miller RJ; Rooker GM; Shuman BA
    Urology; 1996 Mar; 47(3):395-401. PubMed ID: 8633408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous, transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma.
    Miller RJ; Cohen JK; Shuman B; Merlotti LA
    Cancer; 1996 Apr; 77(8):1510-4. PubMed ID: 8608536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience.
    Koppie TM; Shinohara K; Grossfeld GD; Presti JC; Carroll PR
    J Urol; 1999 Aug; 162(2):427-32. PubMed ID: 10411051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy.
    Bales GT; Williams MJ; Sinner M; Thisted RA; Chodak GW
    Urology; 1995 Nov; 46(5):676-80. PubMed ID: 7495120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N; Smolkin ME; Bissonette E; Theodorescu D
    Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results.
    Shinohara K; Connolly JA; Presti JC; Carroll PR
    J Urol; 1996 Jul; 156(1):115-20; discussion 120-1. PubMed ID: 8648771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).
    Hussain M; Tangen CM; Higano C; Schelhammer PF; Faulkner J; Crawford ED; Wilding G; Akdas A; Small EJ; Donnelly B; MacVicar G; Raghavan D;
    J Clin Oncol; 2006 Aug; 24(24):3984-90. PubMed ID: 16921051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryosurgery as a treatment for prostate carcinoma: results and complications.
    Wong WS; Chinn DO; Chinn M; Chinn J; Tom WL; Tom WL
    Cancer; 1997 Mar; 79(5):963-74. PubMed ID: 9041159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation.
    Fitch DL; McGrath S; Martinez AA; Vicini FA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1430-9. PubMed ID: 16765527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A; Walter B; Rogenhofer S; Wieland WF
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
    Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
    Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryosurgical ablation of the prostate for localized adenocarcinoma: a preliminary experience.
    Wake RW; Hollabaugh RS; Bond KH
    J Urol; 1996 May; 155(5):1663-6. PubMed ID: 8627849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring--A one year follow-up.
    Lee F; Bahn DK; McHugh TA; Kumar AA; Badalament RA
    Anticancer Res; 1997; 17(3A):1511-5. PubMed ID: 9179188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological presence of viable prostatic glands on routine biopsy following cryosurgical ablation of the prostate.
    Shuman BA; Cohen JK; Miller RJ; Rooker GM; Olson PR
    J Urol; 1997 Feb; 157(2):552-5. PubMed ID: 8996354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
    Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer.
    Janoff DM; Peterson C; Mongoue-Tchokote S; Peters L; Beer TM; Wersinger EM; Mori M; Garzotto M
    BJU Int; 2005 Sep; 96(4):503-7. PubMed ID: 16104900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.